Matthew S. Block

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 388 citations · Full text

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Mitesh J. Borad, Mia D. Champion, Jan B. Egan et al. · PLoS Genetics · 2014 · 334 citations · Full text

Fgfr Inhibitors, Pathology, Sporadic Intrahepatic Cholangiocarcinoma +19

Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes

Anupam Kotwal, Candace L. Haddox, Matthew S. Block et al. · BMJ Open Diabetes Research & Care · 2019 · 213 citations · Full text

Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer

Evanthia Galanis, Pamela J. Atherton, Matthew J. Maurer et al. · Cancer Research · 2014 · 172 citations · Full text

Immunology, Immunoediting, Pathology +20

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Hui Shen, Brooke L. Fridley, Honglin Song et al. · Nature Communications · 2013 · 169 citations · Full text